Their blockade could avoid deleterious effects due to the hyperexpression cytokine and protecting brain cells [116,117], suggesting that the use of IL6 antibodies in COVID-19 cases blocks the action against several tissues [111]. This evidence concerns the gene IL6 and COVID-19.